维普期刊资源整合服务平台（V6.5）

65篇 您的检索式：作者名="LE COUTRE P"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemic cell and induces apoptosis显示文摘	GAMBACORTI-PASSERINI C le COUTRE P MOLOGNI L	1997	Blood Cells Mol Dis1997，23，3：	1
2	Role of alphal acid glycoprotein in the in vivo resistance of human BCR-ABL(+) leukemic cells to the abl inhibitor ST1571 显示文摘	Gambacorti-Passerini C Barni R le Coutre P	2000	J Natl Cancer Inst2000，92，：	1
3	In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor 显示文摘	Le Coutre P Mologni L Cleris L	1999	J Natl Cancer Inst1999，91，：	1
4	Inhibition of the ABL kinase activity blocks the proliferation of BCR/ABL+ leukemia cells and induces apoptosis 显示文摘	Gambacotti-Passerini C le Coutre P Mologni L	1997	Blood Cells Mol Dis1997，23，：	1
5	Niiotinib (formerly AMN107) , a high selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated phase chronic myelogenous leukemia显示文摘	LE COUTRE P OTTMANN OCG GILES F	2008	Blood2008，111，4：	1
6	Pharmacokinetics and cellular uptake of imatinib and its main metabolite CGP74588 显示文摘	Le Coutre P Kreuzer K A Pursehe S	2004	Cancer Chemother Pharmacol2004，53，4：	1
7	Role of alpha1 acid glycoprotein in the in vivo resistance of human bcr-abl (+)leukemic cells to the abl inhibitor STI571显示文摘	Gambacorti-Passerini C Barni R le Coutre P	2000	J Natl Cancer Inst2000，92，20：	1
8	Induction of resistance to the Abelson inhibitor STI571 in human Leukemia cells through gene amplification 显示文摘	Le Coutre P Tassi E Varella-Garcia M	2000	Blood2000，95，5：	1
9	Inhibitor of the Abl ki- nase activity blocks the proliferation of BCR-ABL + leukemic cells and induces apoptosis显示文摘	Gambacorti PC Le Coutre P Mologni L et 81	1997	Blood Cells Mol Dis1997，23，3：	1
10	Nilolinib(formerlyAMN107), a high selective BCR-ABL tyrosine kinase inhibitor, is active in patients with iraatinib-resistant orintolerant accelerated phase chronic myelogenous leukemia 显示文摘	Le Coutre P Ottmann OG Giles F	2008	Blood2008，111，4：	1
11	Severe peripheral arterial disease during nilotinib therapy显示文摘	Le COUTRE P REA D ABRUZZESE E et ol	2011	J Natl Cancer Inst2011，103，17：	1
12	Induc- tion of resistance to the Abelson inhibitor STI571 in human leuke- mic cells through gene amplification显示文摘	LE COUTRE P TASSI E VARELLA GARCIA M	2000	Blood2000，95，5：	1
13	Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification显示文摘	LE COUTRE P TASSI E VARELLA GARCIA M	2000	Blood2000，95，5：	1
14	Inhibiter of the ABL kinase activity blocks the proliferation of BCR/ABL leukemic cells and induces apoptosis显示文摘	Gambacoti-Passerini C le Coutre P Mologni L	1997	Blood Cells Mol Dis1997，23，：	1
15	In vivo eradication of human BCR/ABL-positive leukemia cells with an ABL kinase inhibitor 显示文摘	le COUTRE P MOLOGNI L CLERIS L	1999	J Natl Cancer Inst1999，91，2：	1
16	Determination of alpha-1 acid glycoprotein in patients with Ph+ chronic myeloid leukemia during the first 13 weeks of therapy with STI571 显示文摘	Le Coutre P Kreuzer KA Na IK	2002	Blood Cells Mol Dis2002，28，1：	1
17	Induction of resistance to the Abelson inhibitor STI571 in human leukemic cells through gene amplification 显示文摘	le Coutre P Tassi E Varella-Garcia M	2000	Blood2000，95，：	1
18	Role of alphal acid glycoprotein in the in vivo resistance of human BCR-ABL+ leukemic cells to the Abl inhibitor ST1571 显示文摘	Gambacorti-Passerini C Barni R le Coutre P	2000	J Natl Cancer Inst2000，10，20：	1
19	Nilntinib (formerly AMN 107), a highly selective bcr abl tyrosine kinase inhibitor, is active in patients with imatinib-resistant or intolerant accelerated phase chronic myelogenous leukemia显示文摘	Le Coutre P Ottmann OG Giles F etal	2008	Blood2008，110，4：	1
20	Induction of resis-tance to the abelson inhibitor STI 571 in human leukemic cells through gene amplification显示文摘	le Coutre P Tassi E Varella-Garcia M	2000	Blood2000，95，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示